Patient-Reported Outcomes of Bleomycin Sclerotherapy for Low-Flow Vascular Malformations and Predictors of Improvement

Wassef M(2015)Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies Pediatrics 136 e203-e214

Blei F(2014)ISSVA classification Semin Pediatr Surg 23 158-161

Adams D(2004)Quality of life in patients with vascular malformations of the lower extremity Br J Plast Surg 57 754-763

Alomari A(2014)Quality of life in patients with congenital vascular malformations Journal of Vascular Surgery Venous and Lymphatic Disorders 2 46-51

Baselga E(2013)Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations Br J Pharmacol 170 1210-1220

Berenstein A(2011)Treatment of lymphatic malformations of head and neck with OK-432 sclerotherapy induce systemic inflammatory response Eur Arch Otorhinolaryngol 268 123-129

Dasgupta R(2002)Histological investigation of veins and venous malformations after injection of sclerosing agents Asian Journal of Oral and Maxillofacial Surgery. 14 226-231

Fishman SJ(2014)Ethanol sclerotherapy for venous malformation ANZ J Surg 33 1649-1655

Breugem CC(2011)Sclerotherapy of lymphangiomas of the head and neck Head Neck 46 912-922

Merkus MP(2011)Sclerotherapy for lymphatic malformations in children: a scoping review J Pediatr Surg 137 244-256

Wassef M(2015)Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies Pediatrics 136 e203-e214

Blei F(2014)ISSVA classification Semin Pediatr Surg 23 158-161

Adams D(2004)Quality of life in patients with vascular malformations of the lower extremity Br J Plast Surg 57 754-763

Alomari A(2014)Quality of life in patients with congenital vascular malformations Journal of Vascular Surgery Venous and Lymphatic Disorders 2 46-51

Baselga E(2013)Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations Br J Pharmacol 170 1210-1220

Berenstein A(2011)Treatment of lymphatic malformations of head and neck with OK-432 sclerotherapy induce systemic inflammatory response Eur Arch Otorhinolaryngol 268 123-129

Dasgupta R(2002)Histological investigation of veins and venous malformations after injection of sclerosing agents Asian Journal of Oral and Maxillofacial Surgery. 14 226-231

Fishman SJ(2014)Ethanol sclerotherapy for venous malformation ANZ J Surg 33 1649-1655

Breugem CC(2011)Sclerotherapy of lymphangiomas of the head and neck Head Neck 46 912-922

Merkus MP(2011)Sclerotherapy for lymphatic malformations in children: a scoping review J Pediatr Surg 137 244-256